TROPHY-U-01, a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint inhibitors: updated safety and efficacy outcomes
Loriot, Y., Petrylak, D.P., Rezazadeh Kalebasty, A., Fléchon, A., Jain, R.K., Gupta, S., Bupathi, M., Beuzeboc, P., Palmbos, P., Balar, A.V., Kyriakopoulos, C.E., Pouessel, D., Sternberg, C.N., Tonelli, J., Sierecki, M., Zhou, H., Grivas, P., Barthélémy, P., Tagawa, S.T.
Published in Annals of oncology (01.04.2024)
Published in Annals of oncology (01.04.2024)
Get full text
Journal Article
733P Testicular cancer: Trends in incidence and demographics from 23,214 cases in California from 2000-2020
Benjamin, D.J., Shrestha, A., Fellman, D., Kalebasty, A. Rezazadeh
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
1766P Urachal cancer: A population-based study of 315 cases in California from 1988-2019
Benjamin, D.J., Shrestha, A., Fellman, D., Cress, R., Rezazadeh Kalebasty, A.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1997P Novel biomarker, ephrinB2 (B2), predicts resistance to treatment and poor overall survival (OS) metastatic urothelial carcinoma (mUC)
Sadeghi, S., Mar, N., Tsao-Wei, D., Siddiqi, I., Freeman, D., Torkko, K., van Bokhoven, A., Flaig, T., Gill, P., Rezazadeh Kalebasty, A., Sonpavde, G.P., Bellmunt, J.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
1803P Phase I/II study of bavdegalutamide, a PROTAC androgen receptor (AR) degrader in metastatic castration-resistant prostate cancer (mCRPC): Radiographic progression-free survival (rPFS) in patients (pts) with AR ligand-binding domain (LBD) mutations
Petrylak, D.P., Garmezy, B., Shen, J., Rezazadeh Kalebasty, A., Sartor, O., Dreicer, R., Agarwal, N., Hussain, M., Percent, I., Heath, E., Gedrich, R., Yu, T., Healey, D., Parameswaran, J., Sternberg, C.N., Gao, X.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
Tolerability and pharmacokinetic analyses of combination therapy with darolutamide (DARO), androgen-deprivation therapy (ADT), and docetaxel (DOC) in patients with metastatic hormone sensitive prostate cancer (mHSPC) from ARASENS
Tombal, B., Smith, M.R., Hussain, M., Saad, F., Fizazi, K., Sternberg, C.N., Crawford, E.D., Kapur, S., Zhang, W., Ploeger, B., Li, R., Kuss, I., Zieschang, C., Wittemer-Rump, S., Rezazadeh Kalebasty, A.
Published in European urology (01.02.2023)
Published in European urology (01.02.2023)
Get full text
Journal Article
A1184 - Tolerability and pharmacokinetic analyses of combination therapy with darolutamide (DARO), androgen-deprivation therapy (ADT), and docetaxel (DOC) in patients with metastatic hormone sensitive prostate cancer (mHSPC) from ARASENS
Tombal, B., Smith, M.R., Hussain, M., Saad, F., Fizazi, K., Sternberg, C.N., Crawford, E.D., Kapur, S., Zhang, W., Ploeger, B., Li, R., Kuss, I., Zieschang, C., Wittemer-Rump, S., Rezazadeh Kalebasty, A.
Published in European urology (01.02.2023)
Published in European urology (01.02.2023)
Get full text
Journal Article
173P Clinical outcomes in stratification subgroups in the ARASENS study in metastatic hormone-sensitive prostate cancer (mHSPC)
Parnis, F., Tombal, B., Hussain, M., Saad, F., Fizazi, K., Sternberg, C.N., Crawford, E.D., Kopyltsov, E., Rezazadeh Kalebasty, A., Alekseev, B.Y., Montesa Pino, A., Ye, D., Melo Cruz, F.J.S., Tammela, T., Suzuki, H., Joensuu, H., Thiele, S., Li, R., Kuss, I., Smith, M.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
917P - Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22
Siefker-Radtke, A.O., Lugowska, I., Tupikowski, K., Andric, Z.G., Rezazadeh Kalebasty, A., Curigliano, G., Vaena, D., Vogl, F.D., Currie, G., Abella, S., Kelly, W.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Clinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22
Siefker-Radtke, A.O., Lugowska, I., Tupikowski, K., Andric, Z.G., Rezazadeh Kalebasty, A., Curigliano, G., Vaena, D., Vogl, F.D., Currie, G., Abella, S., Kelly, W.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
917PClinical activity of vofatamab (V), an FGFR3 selective antibody in combination with pembrolizumab (P) in metastatic urothelial carcinoma (mUC), updated interim analysis of FIERCE-22
Siefker-Radtke, A O, Lugowska, I, Tupikowski, K, Andric, Z G, Rezazadeh Kalebasty, A, Curigliano, G, Vaena, D, Vogl, F D, Currie, G, Abella, S, Kelly, W
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
705MO Sitravatinib (sitra) in combination with nivolumab (nivo) demonstrates clinical activity in checkpoint inhibitor (CPI) naïve, platinum-experienced patients (pts) with advanced or metastatic urothelial carcinoma (UC)
Msaouel, P., Siefker-Radtke, A.O., Sweis, R., Mao, S., Rosenberg, J.E., Vaishampayan, U.N., Kalebasty, A. Rezazadeh, Pili, R., Bupathi, M., Nordquist, L.T., Shaffer, D.R., Davis, N., Zhang, T., Gandhi, S., Christensen, J., Shazer, R., Yan, X., Winter, M., Der-Torossian, H., Iyer, G. Vasudeva
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
LBA52Efficacy and safety of nivolumab in combination with docetaxel in men with metastatic castration-resistant prostate cancer in CheckMate 9KD
Fizazi, K, Gonzalez Mella, P, Castellano, D, Minatta, J N, Rezazadeh Kalebasty, A, Shaffer, D, Vazquez Limon, J C, Armstrong, A J, Sanchez Lopez, H M, Sharkey, B, Saci, A, Li, J, Wang, X, Ciprotti, M, Sathyanarayana, P, Saad, F, Petrylak, D P, Retz, M M, Pachynski, R K, Drake, C
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
LBA14_PR - IMvigor130: Efficacy and safety from a phase III study of atezolizumab (atezo) as monotherapy or combined with platinum-based chemotherapy (PBC) vs placebo + PBC in previously untreated locally advanced or metastatic urothelial carcinoma (mUC)
Grande, E., Galsky, M., Arranz Arija, J.A., De Santis, M., Davis, I.D., De Giorgi, U.F.F., Mencinger, M., Kikuchi, E., Garcia del Muro, X., Gumus, M., Özgüroğlu, M., Rezazadeh Kalebasty, A., Park, S.H., Alekseev, B.Y., Schutz, F.A.B., Li, J.-R., Mecke, A., Mariathasan, S., Thastrom, A., Bamias, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
IMvigor130: Efficacy and safety from a phase III study of atezolizumab (atezo) as monotherapy or combined with platinum-based chemotherapy (PBC) vs placebo + PBC in previously untreated locally advanced or metastatic urothelial carcinoma (mUC)
Grande, E., Galsky, M., Arranz Arija, J.A., De Santis, M., Davis, I.D., De Giorgi, U.F.F., Mencinger, M., Kikuchi, E., Garcia del Muro, X., Gumus, M., Özgüroğlu, M., Rezazadeh Kalebasty, A., Park, S.H., Alekseev, B.Y., Schutz, F.A.B., Li, J.-R., Mecke, A., Mariathasan, S., Thastrom, A., Bamias, A.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
LBA52 - Efficacy and safety of nivolumab in combination with docetaxel in men with metastatic castration-resistant prostate cancer in CheckMate 9KD
Fizazi, K., Gonzalez Mella, P., Castellano, D., Minatta, J.N., Rezazadeh Kalebasty, A., Shaffer, D., Vazquez Limon, J.C., Armstrong, A.J., Sanchez Lopez, H.M., Sharkey, B., Saci, A., Li, J., Wang, X., Ciprotti, M., Sathyanarayana, P., Saad, F., Petrylak, D.P., Retz, M.M., Pachynski, R.K., Drake, C.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
LBA14_PRIMvigor130: Efficacy and safety from a phase III study of atezolizumab (atezo) as monotherapy or combined with platinum-based chemotherapy (PBC) vs placebo + PBC in previously untreated locally advanced or metastatic urothelial carcinoma (mUC)
Grande, E, Galsky, M, Arranz Arija, J A, De Santis, M, Davis, I D, De Giorgi, U F F, Mencinger, M, Kikuchi, E, Garcia del Muro, X, Gumus, M, Özgüroğlu, M, Rezazadeh Kalebasty, A, Park, S H, Alekseev, B Y, Schutz, F A B, Li, J-R, Mecke, A, Mariathasan, S, Thastrom, A, Bamias, A
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Efficacy and safety of nivolumab in combination with docetaxel in men with metastatic castration-resistant prostate cancer in CheckMate 9KD
Fizazi, K., Gonzalez Mella, P., Castellano, D., Minatta, J.N., Rezazadeh Kalebasty, A., Shaffer, D., Vazquez Limon, J.C., Armstrong, A.J., Sanchez Lopez, H.M., Sharkey, B., Saci, A., Li, J., Wang, X., Ciprotti, M., Sathyanarayana, P., Saad, F., Petrylak, D.P., Retz, M.M., Pachynski, R.K., Drake, C.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article